Following up first doses of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines with second doses of the Moderna or Novavax jabs will generate robust immune responses against COVID-19, according to researchers running the ...
Dec 7, 2021
0
115
Antibiotic consumption rates grew by 46 percent after 2000, according to findings which also suggest lack of treatment access in some areas.
Nov 16, 2021
0
103
Radcliffe Department of Medicine researchers have identified the gene responsible for doubling the risk of respiratory failure from COVID-19. Sixty percent of people with South Asian ancestry carry the high-risk genetic signal, ...
Nov 5, 2021
0
374
Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.
Oct 26, 2021
0
22
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing ...
Oct 11, 2021
0
74
Researchers from the University of Oxford have today announced the results of a study into thrombocytopenia (a condition with low platelet counts) and thromboembolic events (blood clots) following vaccination for COVID-19, ...
Aug 27, 2021
2
1427
Researchers at the University of Oxford have now uncovered a new target for sleep investigations within the mammalian brain—the cerebral cortex. The paper was published today in Nature Neuroscience.
Aug 3, 2021
0
632
A study involving nearly half a million people in China reveals a clear link between cooking with wood or coal, and an increased risk of major eye diseases that can lead to blindness, according to a report published today ...
Jul 30, 2021
4
296
The rapid spread of the Alpha variant of COVID-19 resulted from biological changes in the virus and was enhanced by large numbers of infected people "exporting" the variant to multiple parts of the UK, in what the researchers ...
Jul 22, 2021
0
292
Adenovirus vaccine vectors, such as the ChAdOx1 nCov-19 construct which has risen to prominence as a major vaccine for COVID-19, may generate robust long-term immune system responses, according to scientists from the Universities ...
Jul 15, 2021
0
198
